Education Can Promote Self-Management in CVD Conditions

Share this content:
Education Can Promote Self-Management in CVD Conditions
Education Can Promote Self-Management in CVD Conditions

WEDNESDAY, June 21, 2017 (HealthDay News) -- Therapeutic patient education interventions can promote self-management in selected cardiovascular conditions, according to a scientific statement published online June 19 in Circulation: Cardiovascular Quality and Outcomes.

Susan Barnason, Ph.D., R.N., from the University of Nebraska Medical Center in Omaha, and colleagues conducted an integrative review of the literature to analyze published studies of therapeutic patient education for self-management in selected cardiovascular conditions.

The researchers identified variability in methodological approaches across setting and disease conditions. Interventions that were tailored to individual patient needs, used multiple components to improve self-management outcomes, and often used multidisciplinary approaches were the most effective.

"This synthesis of evidence expands the base of knowledge related to the development of patient self-management skills and provides direction for more rigorous research," the authors write. "Recommendations are provided to guide the implementation of therapeutic patient education in clinical practice and the design of comprehensive self-management interventions to improve outcomes for cardiovascular patients."

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: More Than 400 Sickened by McDonald's Salads

CDC: More Than 400 Sickened by McDonald's Salads

Multistate outbreak of Cyclosporiasis linked to McDonald's Fresh Express Salad Mix

Jury Awards 289 Million in Case Linking Roundup to Man's Cancer

Jury Awards $289 Million in Case Linking Roundup ...

Case could set a precedent for other lawsuits against Monsanto, the manufacturer of Roundup

Prenatal Tdap Vaccination Not Linked to Autism Risk

Prenatal Tdap Vaccination Not Linked to Autism Risk

No increased risk of autism spectrum disorder in association with prenatal Tdap vaccination

is free, fast, and customized just for you!




Already a member?

Sign In Now »